ACCELERON PHARMA INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
ACCELERON PHARMA INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 1.72 million shares as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2021-11-04
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.72M shares.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.86M shares.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.78M shares.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.73M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2021-09-30 | 1.72M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 1.86M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 1.78M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 1.73M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 1.84M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 1.88M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 2.33M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 2.40M shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 2.33M shares 10-Q · filed 2019-11-06 |
| 2018-12-31 | 2.01M shares 10-K · filed 2019-02-27 |
| 2017-12-31 | 2.11M shares 10-K · filed 2018-02-27 |
| 2016-12-31 | 1.78M shares 10-K · filed 2017-03-01 |
| 2015-12-31 | 2.00M shares 10-K · filed 2016-02-25 |
| 2015-06-30 | 2.02M shares 10-Q · filed 2015-08-06 |
| 2015-03-31 | 2.08M shares 10-Q · filed 2015-05-07 |